Cite
APA Citation
Forker, L., Sioletic, S., Shenjere, P., Irlam, J., Valentine, H., Hughes, D., Hughes, A., Gaunt, P., Robinson, M., & West, C. (n.d.). the hypoxia marker CA-IX is prognostic in soft tissue sarcoma patients treated in the UK phase III VORTEX trial. European journal of cancer, 61, S70–. http://access.bl.uk/ark:/81055/vdc_100034056183.0x000054